Perspective Therapeutics Inc. logo

Perspective Therapeutics Inc.

CATX | AMEX
Chart Builder DCF Calculator
$2.90
-$0.07 (-2.36%)
Sep 22, 2026, 2:03 PM ET · Market open

Market Data

Market Cap
$338.72M
Enterprise Value
$104.21M
Beta
1.80
Average Volume
1.54M
Shares Outstanding (Diluted)
120.65K
Shares Change YoY
-99.83%
Institutional Ownership
N/A
Exchange
AMEX
ISIN
US46489V3024

Price Performance

Price Change 1M
-10.5%
Price Change 3M
-1.0%
Price Change 6M
-34.3%
Price Change YTD
6.5%
Price Change 1Y
-10.0%
Price Change 3Y
-0.7%
Price Change 5Y
-55.0%
1M CAGR (ann.)
-1.0%
1Y CAGR (ann.)
-9.7%
5Y CAGR (ann.)
-15.7%
All-Time CAGR
-12.7%

Valuation

PE Ratio
-2.08
Forward PE
N/A
PEG Ratio
0.11
Forward PEG
-0.36
PS Ratio
828.16
Forward PS
982.20
PB Ratio
1.05
P/FCF Ratio
-2.79
P/Adj. FCF Ratio
-2.58
P/OCF Ratio
-2.36
EV/Sales
254.78
EV/EBIT
-0.87
EV/EBITDA
-0.90
EV/FCF
-0.86
Earnings Yield
-48.1%
FCF Yield
-35.8%
Adj. FCF Yield
-38.8%

Financial Health

Net Cash
$234.51M
Total Debt
$2.37M
Cash & Short-Term Investments
$236.88M
Total Assets
$392.03M
Current Ratio
6.61
Quick Ratio
6.61
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.02
Debt / FCF
-0.02
OCF / Debt
-39.34
Interest Coverage
-410.60
Altman Z-Score
1.22
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
-419.4%
Operating Profit Margin
-30619.1%
EBITDA Margin
-31750.8%
Net Profit Margin
-31812.6%
FCF Margin
-29630.1%
Adj. FCF Margin
-32090.7%
SBC / Revenue
2749.7%
SBC Impact (per share)
-8.3%

Returns

Return on Assets
-29.7%
Return on Equity
-41.6%
Return on Invested Capital
-34.9%
Return on Capital Employed
-35.2%
Return on Tangible Assets
-33.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-61.0%
Revenue CAGR 5Y
-47.3%
Revenue CAGR 10Y
-21.8%
EPS CAGR 3Y
-14.1%
EPS CAGR 5Y
-42.2%
EPS CAGR 10Y
-33.8%
FCF CAGR 3Y
-55.6%
FCF CAGR 5Y
-54.4%
FCF CAGR 10Y
-37.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
17.5%
Revenue Growth Next 3Y
458.7%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.24
EPS Growth Est (next Q)
-31.4%
Revenue Est (next Q)
$62.15K
Revenue Growth Est (next Q)
-70.3%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$11
Price Target Upside
270.4%

Cash Flow

Operating Cash Flow
$-93.07M
Free Cash Flow
$-121.19M
Adj. Free Cash Flow
$-131.25M
FCF Per Share
-$1.64
OCF Per Share
-$1.26
OCF/S Ratio
-25428.1%

Income Statement

Revenue
$409K
Gross Profit
$-2.5M
Operating Income
$-125.23M
EBITDA
$-116.21M
Net Income
$-116.43M
EPS (Diluted)
-$1.43
Revenue / Employee
$2.48K
Profit / Employee
$-705.66K
Employees
165

© 2026 bestshares.com. All rights reserved.